Sargent Investment Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,465
| Closed | -$210K | – | 245 |
|
|
2024
Q4 | $210K | Sell |
4,465
-3,628
| -45% | -$171K | 0.03% | 219 |
|
|
2024
Q3 | $266K | Hold |
8,093
| – | – | 0.05% | 179 |
|
|
2024
Q2 | $220K | Sell |
8,093
-147
| -2% | -$4K | 0.04% | 198 |
|
|
2024
Q1 | $300K | Sell |
8,240
-2,877
| -26% | -$105K | 0.07% | 159 |
|
|
2023
Q4 | $225K | Buy |
+11,117
| New | +$225K | 0.05% | 188 |
|
|
2023
Q3 | – | Sell |
-10,045
| Closed | -$182K | – | 213 |
|
|
2023
Q2 | $182K | Sell |
10,045
-534
| -5% | -$9.65K | 0.04% | 187 |
|
|
2023
Q1 | $133K | Buy |
10,579
+221
| +2% | +$2.78K | 0.04% | 189 |
|
|
2022
Q4 | $152K | Sell |
10,358
-500
| -5% | -$7.33K | 0.05% | 181 |
|
|
2022
Q3 | $187K | Buy |
+10,858
| New | +$187K | 0.06% | 168 |
|